Axon Stock Faces May 6 Test After 34% Revenue Growth
Axon stock heads into May 6 with first-quarter 2026 results due after market close, and the setup is simple: revenue is expected to rise, but so are the costs tied to getting there. The quarter will show whether demand for devices and software translated into faster sales or whether expenses narrowed the benefit for shareholders.
May 6 Brings $780.6 Million
$780.6 million is the Zacks Consensus Estimate for first-quarter revenue, a 29.3% increase from the year-ago quarter. Axon Enterprise, Inc. is scheduled to report after market close on May 6, so the first hard read on demand will land only after regular trading ends.
$1.66 per share is the consensus earnings estimate, and it has held steady in the past 60 days. That stability leaves less room for a surprise from the estimate itself, even though the figure still points to 17.7% growth from the same quarter last year.
$2.15 per share was Axon’s last reported quarterly profit, which topped the consensus estimate by 28.7%. In the preceding four quarters, the company beat expectations three times and missed once, with an average surprise of 12.3%.
Connected Devices And Axon 911
$423 million is the consensus revenue estimate for Connected Devices, where solid demand for TASER 10 products and higher cartridge sales were expected to help the quarter. Strong customer response for Axon Body 4 and demand for virtual reality training services were also expected to feed that segment.
$354 million is the expected net sales figure for Software & Services, where analysts expected the addition of new users and associated devices to the AXON network to add support. Continued momentum in digital evidence management and demand for premium add-on features were also expected to lift that business.
February 2026 brought another variable into the quarter: Axon acquired Carbyne, a provider of cloud contact center technology solutions to public safety agencies. The deal integrated Carbyne’s cloud-native 911 technology into the Axon ecosystem to create Axon 911, giving investors a new piece of the growth story to weigh against the cost of folding it in.
Costs And Earnings ESP
0.00% is Axon’s Earnings ESP, with both the Zacks Consensus Estimate and the Most Accurate Estimate pegged at $1.66 per share. That leaves the quarter anchored to the existing earnings view rather than to a wider spread between forecasts.
Escalating costs and operating expenses are the pressure point. High costs related to business integration activities, increased wages, and stock-based compensation were expected to weigh on the bottom line, so the report will show whether top-line growth was enough to offset those items.
May 6 is the moment investors get the answer in the numbers. If revenue lands near the consensus figures, the focus shifts fast to margin pressure and the cost of expanding Axon’s software and devices business at the same time.
